A nudge intended to remind general practice residents to receive an influenza vaccine, though deemed “acceptable,” did not increase uptake, according to researchers.

A study involving more than 1,000 patients identified cardiac involvement, age and race as attributes that could differentiate multisystem inflammatory syndrome in children from severe COVID-19, researchers reported in JAMA.

A financial incentive that the Ontario government provides to eligible Canadian family physicians who work outside regular business hours was associated with a reduction in nonurgent ED visits, according to researchers.

The FDA granted breakthrough therapy designation to tipifarnib for treatment of certain patients with head and neck squamous cell carcinoma, according to the agent’s manufacturer.

A self-help and peer counseling intervention helped patients with rare chronic diseases cope better than usual care alone, according to results of a randomized clinical trial published in JAMA Psychiatry.

With proper dosing — 5 mg/kg or less per day — the risk for retinal toxicity associated with hydroxychloroquine use is less than 2% for up to 10 years, according to a joint statement from four medical societies.

Pamela Kunz, MD, said she became interested in joining the Women in Oncology Peer Perspective Board because the initiative can provide a platform for women to share experiences and advance research.

In this video perspective from the virtual ESCRS winter meeting, Nino Hirnschall, MD, PhD, discusses key topics of a symposium he moderated on optimizing refractive outcomes of cataract surgery.

Stereotactic body radiotherapy appeared safe and effective for men with high-risk prostate cancer, according to an analysis of data from a consortium of seven institutional phase 2 studies and registries.

The CDC’s Advisory Committee on Immunization Practices voted Wednesday to shorten the recommendation for rabies PrEP to a two-dose vaccine schedule, aligning with international guidance.